Filing Details
- Accession Number:
- 0001104659-22-120514
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-21 08:39:24
- Reporting Period:
- 2022-11-17
- Accepted Time:
- 2022-11-21 08:39:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1251213 | Ron Bentsur | C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chairman & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-17 | 250 | $7.24 | 3,014,359 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-18 | 500 | $7.23 | 3,014,859 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Includes 96,759 shares of restricted stock and 120,000 restricted stock units.